Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.
暂无分享,去创建一个
D. Goff | W. Cushman | W. White | B. Falkner | R. Toto | K. Ferdinand | S. Textor | R. Carey | T. Giles | D. Calhoun | T. Murphy | D. Sica | A. White | D. Jones | D. A. Calhoun | D. Jones | S. Textor | D. C. Goff | T. P. Murphy | R. D. Toto | A. White | W. C. Cushman | W. White | D. Sica | K. Ferdinand | T. D. Giles | B. Falkner | R. M. Carey
[1] D. Reda,et al. Results of combination anti-hypertensive therapy after failure of each of the components. Department of Veterans Affairs Cooperative Study Group on Anti-hypertensive Agents. , 1995, Journal of human hypertension.
[2] N. Fineberg,et al. Association Between the CYP 3 A 5 Genotype and Blood Pressure , 2005 .
[3] G. Stergiou,et al. Additive hypotensive effect of angiotensin-converting enzyme inhibition and angiotensin-receptor antagonism in essential hypertension. , 2000, Journal of cardiovascular pharmacology.
[4] John E Hall,et al. The kidney, hypertension, and obesity. , 2003, Hypertension.
[5] N. Bansal,et al. Blood pressure control in the hypertension clinic. , 2003, American journal of hypertension.
[6] R. Stack,et al. Progression of renal artery stenosis in patients undergoing cardiac catheterization. , 1998, American heart journal.
[7] B. Egan. Nonnarcotic Analgesic Use and the Risk of Hypertension in US Women , 2002 .
[8] B. Davis,et al. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). , 2002, Journal of clinical hypertension.
[9] J. Virtamo,et al. Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertension , 2005, BMC Medical Genetics.
[10] C. Gomez-Sanchez,et al. Pathophysiology of adrenal hypertension. , 2002, Seminars in nephrology.
[11] F. Cuccurullo,et al. Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. , 2005, American journal of hypertension.
[12] A. Dominiczak,et al. Better blood pressure control: how to combine drugs , 2003, Journal of Human Hypertension.
[13] T. Obara,et al. The role of epinephrine, norepinephrine, and dopamine in blood pressure disturbances in patients with pheochromocytoma , 1992, World Journal of Surgery.
[14] G. Beck,et al. The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease , 1994 .
[15] W. White,et al. Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis. , 2002, The American journal of cardiology.
[16] L. Ruilope,et al. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. , 1998, Hypertension.
[17] Erry,et al. Prospective study of the association between sleep-disordered breathing and hypertension. , 2000, The New England journal of medicine.
[18] N. Blakeman,et al. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients , 1994, Journal of hypertension.
[19] T. Thien,et al. Accuracy of the Omron RX-M, an automated blood pressure measuring device, measuring blood pressure at the wrist, according to a modified British Hypertension Society protocol , 2004, Blood pressure monitoring.
[20] A. Diedrich,et al. Modafinil Elicits Sympathomedullary Activation , 2005, Hypertension.
[21] G. Ogedegbe,et al. A Systematic Review of the Effects of Home Blood Pressure Monitoring on Medication Adherence , 2006, Journal of clinical hypertension.
[22] P. Ferrari. Cortisol and the renal handling of electrolytes: role in glucocorticoid-induced hypertension and bone disease. , 2003, Best practice & research. Clinical endocrinology & metabolism.
[24] G. Arnaldi,et al. Cardiovascular Risk In Cushing's Syndrome , 2005, Pituitary.
[25] D. Calhoun,et al. Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension , 2002, Hypertension.
[26] E. Ernst. The RiskBenefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava , 2002, Annals of Internal Medicine.
[27] M. Brown,et al. Is resistant hypertension really resistant? , 2001, American journal of hypertension.
[28] J. Caro,et al. Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[29] N. Markandu,et al. Modest Salt Reduction Lowers Blood Pressure in Isolated Systolic Hypertension and Combined Hypertension , 2005, Hypertension.
[30] Teemu J Niiranen,et al. A comparison of home measurement and ambulatory monitoring of blood pressure in the adjustment of antihypertensive treatment. , 2005, American journal of hypertension.
[31] B. Walker,et al. Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess. , 1994, Endocrinology and metabolism clinics of North America.
[32] H. Black,et al. Resistant hypertension revisited: a comparison of two university-based cohorts. , 2005, American journal of hypertension.
[33] M. Muiesan,et al. Left ventricular structural and functional characteristics in Cushing's syndrome. , 2003, Journal of the American College of Cardiology.
[34] M. D. De Martino,et al. Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission. , 2003, The Journal of clinical endocrinology and metabolism.
[35] E. Yiannakopoulou,et al. Adherence to antihypertensive treatment: a critical factor for blood pressure control. , 2005 .
[36] M. Omura,et al. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. , 2004, Hypertension research : official journal of the Japanese Society of Hypertension.
[37] H. Black,et al. Comparison of nifedipine alone and with diltiazem or verapamil in hypertension. , 1996, Hypertension.
[38] S. Textor. Progressive hypertension in a patient with "incidental" renal artery stenosis. , 2002, Hypertension.
[39] R. Hermida,et al. Effects of Time of Day of Treatment on Ambulatory Blood Pressure Pattern of Patients With Resistant Hypertension , 2005, Hypertension.
[40] G Parati,et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. , 1999, JAMA.
[41] Samy I McFarlane,et al. Hypertension in patients with cushing’s disease: Pathophysiology, diagnosis, and management , 2005, Current hypertension reports.
[42] G. Murray,et al. Secondary hypertension in a blood pressure clinic. , 1987, Archives of internal medicine.
[43] J. Coresh,et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). , 2001, Archives of internal medicine.
[44] Crispin Jenkinson,et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial , 2002, The Lancet.
[45] M. F. Michelis,et al. Effectiveness of furosemide in uncontrolled hypertension in the elderly: role of renin profiling. , 2003, American journal of hypertension.
[46] A. Gederlini,et al. Primary Aldosteronism and Hypertensive Disease , 2003, Hypertension.
[47] J. Bakker,et al. Renal artery stenosis and accessory renal arteries: accuracy of detection and visualization with gadolinium-enhanced breath-hold MR angiography. , 1998, Radiology.
[48] Gianfranco Parati,et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. , 1999 .
[49] T. Zelinka,et al. Increased blood pressure variability in pheochromocytoma compared to essential hypertension patients , 2005, Journal of hypertension.
[50] A. Avenell,et al. Effects of Weight Loss in Overweight/Obese Individuals and Long-Term Hypertension Outcomes: A Systematic Review , 2005, Hypertension.
[51] P. Conlin,et al. Effect of Indomethacin on Blood Pressure Lowering by Captopril and Losartan in Hypertensive Patients , 2000, Hypertension.
[52] A. de la Sierra,et al. Effect of alcohol abstinence on blood pressure: assessment by 24-hour ambulatory blood pressure monitoring. , 1999, Hypertension.
[53] A. Iskandrian,et al. Prevalence of renal artery stenosis in high-risk veterans referred to cardiac catheterization. , 2003, Journal of hypertension.
[54] R. Day,et al. Do Nonsteroidal Anti-inflammatory Drugs Affect Blood Pressure? A Meta-Analysis , 1994, Annals of Internal Medicine.
[55] K. Radack,et al. Ibuprofen interferes with the efficacy of antihypertensive drugs. A randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen. , 1987, Annals of internal medicine.
[56] J. Peter,et al. Sleep‐related breathing disorder is an independent risk factor for uncontrolled hypertension , 2000, Journal of hypertension.
[57] P. Krijnen,et al. Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[58] D. Calhoun,et al. Efficacy of low-dose spironolactone in subjects with resistant hypertension. , 2003, American journal of hypertension.
[59] E. Yiannakopoulou,et al. Adherence to antihypertensive treatment: a critical factor for blood pressure control , 2005, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[60] D. Beevers,et al. The ‘Birmingham Hypertension Square’ for the optimum choice of add-in drugs in the management of resistant hypertension , 1998, Journal of Human Hypertension.
[61] W. Young,et al. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. , 2003, The Journal of clinical endocrinology and metabolism.
[62] S. Textor,et al. Resistant Hypertension: Comparing Hemodynamic Management to Specialist Care , 2002, Hypertension.
[63] Arya M. Sharma,et al. Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. , 2004, American journal of hypertension.
[64] O. Ohlsson,et al. Hypertension, levels of serum gamma glutamyl transpeptidase and degree of blood pressure control in middle-aged males. , 2009, Acta medica Scandinavica.
[65] L. Wilkins. Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial. , 1990, Circulation.
[66] D. Reda,et al. Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. , 1995, The New England journal of medicine.
[67] G. Mancia,et al. Obstructive Sleep Apnea–Dependent and –Independent Adrenergic Activation in Obesity , 2005, Hypertension.
[68] A. House,et al. Increased sodium intake correlates with greater use of antihypertensive agents by subjects with chronic kidney disease. , 2005, American journal of hypertension.
[69] T. Douglas Bradley,et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension , 2001, Journal of hypertension.
[70] P. Torjesen,et al. Low-renin status in therapy-resistant hypertension: a clue to efficient treatment , 2004, Journal of hypertension.
[71] W. White,et al. Effects of Celecoxib on Ambulatory Blood Pressure in Hypertensive Patients on ACE Inhibitors , 2002, Hypertension.
[72] O. Olivieri,et al. Aldosterone to Renin ratio in a primary care setting: the Bussolengo study. , 2004, The Journal of clinical endocrinology and metabolism.
[73] Arya M. Sharma,et al. Weight Loss and the Renin-Angiotensin-Aldosterone System , 2005, Hypertension.
[74] G. Mansoor. Herbs and alternative therapies in the hypertension clinic. , 2001, American journal of hypertension.
[75] N. Markandu,et al. Sodium Restriction in Hypertensive Patients Treated With a Converting Enzyme Inhibitor and a Thiazide , 1991, Hypertension.
[76] T. Zeller. Renal artery stenosis , 2007, Current treatment options in cardiovascular medicine.
[77] W. Willett,et al. Nonnarcotic Analgesic Use and the Risk of Hypertension in US Women , 2002, Hypertension.
[78] L. Lind,et al. Prognostic significance of 24-h ambulatory blood pressure characteristics for cardiovascular morbidity in a population of elderly men , 2004, Journal of hypertension.
[79] J. Stradling,et al. Sleep · 6: Obstructive sleep apnoea/hypopnoea syndrome and hypertension , 2004, Thorax.
[80] E. McCarthy,et al. Combined alpha/beta-blockade versus beta 1-selective blockade in essential hypertension in black and white patients. , 1990, Clinical pharmacology and therapeutics.
[81] G. Bakris. A practical approach to achieving recommended blood pressure goals in diabetic patients. , 2001, Archives of internal medicine.
[82] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[83] T. Young,et al. The occurrence of sleep-disordered breathing among middle-aged adults. , 1993, The New England journal of medicine.
[84] G. Chatellier,et al. Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. , 2005, The Journal of clinical endocrinology and metabolism.
[85] Lei Xu,et al. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[86] P. Watkins,et al. CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults. , 2003, Journal of applied physiology.
[87] A. Lincoff,et al. The role of spironolactone in the treatment of patients with refractory hypertension. , 2001, American journal of hypertension.
[88] C. Gomez-Sanchez,et al. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. , 2000, The Journal of clinical endocrinology and metabolism.
[89] Sanford H. Levy. The risk-benefit profile of commonly used herbal therapies. , 2002, Annals of internal medicine.
[90] S. Sheps,et al. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. , 1981, Mayo Clinic proceedings.
[91] A. de Boer,et al. Rate and determinants of 10-year persistence with antihypertensive drugs , 2005, Journal of hypertension.
[92] I. Os,et al. Controlling systolic blood pressure is difficult in patients with diabetic kidney disease exhibiting moderate‐to‐severe reductions in renal function , 2005, Blood pressure.
[93] G. Bray,et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. , 1997, The New England journal of medicine.
[94] E. Muxfeldt,et al. Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension , 2003, Blood pressure monitoring.
[95] P. Lavie,et al. Sleep apnea syndrome: a possible contributing factor to resistant. , 2001, Sleep.
[96] S. Turner,et al. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. , 2005, Clinical chemistry.
[97] E. Vittinghoff,et al. Control of Hypertension in Adults With Chronic Kidney Disease in the United States , 2005, Hypertension.
[98] J. Lau,et al. Effectiveness of Management Strategies for Renal Artery Stenosis: A Systematic Review , 2006, Annals of Internal Medicine.
[99] K. Clark,et al. Association of Sleep-Disordered Breathing, Sleep Apnea, and Hypertension in a Large Community- Based Study , 2000 .
[100] T. Leiner,et al. Contemporary imaging techniques for the diagnosis of renal artery stenosis , 2005, European Radiology.
[101] Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. , 1967, JAMA.
[102] M. Stampfer,et al. Non-Narcotic Analgesic Dose and Risk of Incident Hypertension in US Women , 2005, Hypertension.
[103] D. Calhoun,et al. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. , 2004, Chest.
[104] G. Bray,et al. Effects of Diet and Sodium Intake on Blood Pressure: Subgroup Analysis of the DASH-Sodium Trial , 2001, Annals of Internal Medicine.
[105] F. Visseren,et al. Multidisciplinary Vascular Screening Program Modestly Improves the Medical Treatment of Vascular Risk Factors , 2005, Cardiovascular Drugs and Therapy.
[106] B. Rosner,et al. Effectiveness and Costs of Veterans Affairs Hypertension Clinics , 1994, Medical care.
[107] B. Egan,et al. Insulin resistance and cardiovascular disease. , 2001, American journal of hypertension.
[108] R. Unwin,et al. Pontefract cakes can be bad for you: refractory hypertension and liquorice excess. , 1999, Nephrology, Dialysis and Transplantation.
[109] D. Gu,et al. Alcohol intake and hypertension subtypes in Chinese men , 2005, Journal of hypertension.
[110] T. Goodfriend,et al. An oxidized derivative of linoleic acid affects aldosterone secretion by adrenal cells in vitro. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.
[111] B. Davis,et al. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.
[112] P. Seed,et al. Clinical evaluation of an automated oscillometric blood pressure wrist device , 2004, Blood pressure monitoring.
[113] J. Laragh. Laragh's lessons in pathophysiology and clinical pearls for treating hypertension. , 2001, American journal of hypertension.
[114] A. Logan,et al. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex , 2003, European Respiratory Journal.
[115] M. Kikuya,et al. Prognostic Significance of Blood Pressure and Heart Rate Variabilities: The Ohasama Study , 2000, Hypertension.
[116] C. Guilleminault,et al. Long-term effects of nasal continuous positive airway pressure on vasodilatory endothelial function in obstructive sleep apnea syndrome , 2005, Sleep and Breathing.
[117] Thomas Penzel,et al. Effect of Nasal Continuous Positive Airway Pressure Treatment on Blood Pressure in Patients With Obstructive Sleep Apnea , 2003, Circulation.
[118] M. Birrer,et al. Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study. , 2002, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[119] P. Lavie,et al. Plasma levels of nitric oxide and L-arginine in sleep apnea patients , 2003, Journal of Molecular Neuroscience.
[120] W. Scherbaum,et al. Human adipocytes secrete mineralocorticoid-releasing factors , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[121] Ihab Hajjar,et al. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. , 2003, JAMA.
[122] G. Beck,et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. , 1994, The New England journal of medicine.
[123] M. Stowasser,et al. HIGH INCIDENCE OF PRIMARY ALDOSTERONISM IN 199 PATIENTS REFERRED WITH HYPERTENSION , 1994, Clinical and experimental pharmacology & physiology.
[124] D. Lloyd‐Jones,et al. Treatment and Control of Hypertension in the Community: A Prospective Analysis , 2002, Hypertension.
[125] G. Bergus,et al. Comparative Antihypertensive Effects of Hydrochlorothiazide and Chlorthalidone on Ambulatory and Office Blood Pressure , 2006, Hypertension.
[126] L. Mantovani,et al. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care , 2005, Journal of hypertension.
[127] Daniel W. Jones,et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. , 2005, Hypertension.
[128] P. Krijnen,et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. , 2000, The New England journal of medicine.
[129] N. Fineberg,et al. Association Between the CYP3A5 Genotype and Blood Pressure , 2005, Hypertension.
[130] E. McCarthy,et al. Combined α/β‐blockade versus β1‐selective blockade in essential hypertension in black and white patients , 1990 .
[131] F. Luft,et al. Review of Salt Restriction and the Response to Antihypertensive Drugs Satellite Symposium on Calcium Antagonists , 1988, Hypertension.
[132] W. Ambrosius,et al. Improvement in Blood Pressure With Inhibition of the Epithelial Sodium Channel in Blacks With Hypertension , 2005, Hypertension.
[133] Daniel Levy,et al. Differential Control of Systolic and Diastolic Blood Pressure: Factors Associated With Lack of Blood Pressure Control in the Community , 2000, Hypertension.
[134] N. Douglas,et al. Treatment with Continuous Positive Airway Pressure Is Not Effective in Patients with Sleep Apnea but No Daytime Sleepiness , 2001, Annals of Internal Medicine.
[135] N. Fineberg,et al. Dietary sodium restriction as adjunctive treatment of hypertension. , 1988, JAMA.
[136] Yutaka Imai,et al. Ambulatory Blood Pressure and 10-Year Risk of Cardiovascular and Noncardiovascular Mortality: The Ohasama Study , 2005, Hypertension.
[137] D. Calhoun,et al. Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension. , 2005, American journal of hypertension.
[138] G. Stergiou,et al. Comparison of antihypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapy , 2005, Journal of hypertension.
[139] R. Berg,et al. Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[140] Diederick E. Grobbee,et al. Influence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials , 2003, Hypertension.
[141] G. MacGregor,et al. Effect of longer-term modest salt reduction on blood pressure. , 2000, The Cochrane database of systematic reviews.
[142] D. Sica. Chlorthalidone: has it always been the best thiazide-type diuretic? , 2006, Hypertension.